Benitec Biopharma Inc (NASDAQ:BNTC)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BNTC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BNTC

  • Market Cap$12.480m
  • SymbolNASDAQ:BNTC
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS08205P1003

Company Profile

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV).Benitec Biopharma Ltd is active in the healthcare domain. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology.

Latest BNTC news

Currently there for this company. Visit our news hub for other news .